Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

194.93B

Market cap194.93B

Price-Earnings ratio

11.04

Price-Earnings ratio11.04

Dividend yield

2.61%

Dividend yield2.61%

Average volume

16.30M

Average volume16.30M

High today

$46.11

High today$46.11

Low today

$45.13

Low today$45.13

Open price

$45.56

Open price$45.56

Volume

3.58M

Volume3.58M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Benzinga 24m

Novo Nordisk Stock Is Gaining Thursday: What's Going On? - Novo Nordisk - Benzinga

...

Benzinga 24m

Novo Nordisk Scores Major Court Win, Dutch Judge Halts Compounded Semaglutide Nasal Spray

Dutch judges have issued a preliminary injunction against a European compounding firm, forcing an immediate halt to sales of an unauthorized semaglutide nasal s...

CNBC 46m

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Key Points Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. But while investors cheered Lilly's results, they...

Analyst ratings

54%

of 37 ratings

Buy

37.8%

Hold

54.1%

Sell

8.1%

More NVO News

TipRanks 3h

Novo Nordisk price target raised to $47 from $45 at BMO Capital

BMO Capital analyst Evan Seigerman raised the firm’s price target on Novo Nordisk (NVO) to $47 from $45 and keeps a Market Perform rating on the shares. Novo No...

Seeking Alpha 4h

Amazon delivers GLP-1s for $50 per month for Medicare recipients

Amazon Pharmacy (AMZN) has joined a federal program to offer GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) to eligible Medicare enrollees...

Simply Wall St 19h

Novo Nordisk Stock May Be Below Fair Value On ZEUS Trial Fallout

After a three year stretch where Novo Nordisk stock has declined 50.5%, the valuation picture now looks more supportive than the share price performance suggest...

CNBC 19h

We're increasing our Eli Lilly price target after another beat-and-raise quarter

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company's portfolio of GLP-1 drugs continues to...

MarketWatch 22h

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

In August 2024, Novo Nordisk bused its employees to the sprawling Roskilde fairgrounds outside Copenhagen for its annual summer party. The Danish company had ho...

Nasdaq 22h

Novo Nordisk Wins Dutch Court Injunction Against Compounded Semaglutide Nasal Spray

(RTTNews) - Novo Nordisk A/S (NVO) said Wednesday it secured a preliminary injunction from the District Court of The Hague against Ceban Ziekenhuisfarmacie B.V....

Bloomberg 23h

European Stocks Subdued as HSBC and Novo Nordisk Lead Declines

Markets European Stocks Subdued as HSBC and Novo Nordisk Lead Declines Facebook X LinkedIn Email Link Gift Facebook X LinkedIn Email Link Gift Gift this article...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.